Literature DB >> 2843776

Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus.

A D Friedman1, S J Triezenberg, S L McKnight.   

Abstract

A virion protein of herpes simplex virus type 1 (HSV-1) specifically and potently activates transcription of the viral immediate early genes. Appropriate function of this protein, termed VP16, depends on an acidic transcriptional activation domain located within the 78 carboxyl-terminal amino acids of the protein. Mutated forms of the protein lacking this acidic domain lose the ability to activate transcription, and can dominantly interfere with the trans-activation function of native VP16 (ref. 1). We have prepared stably transformed mouse L cells that constitutively express a form of VP16 lacking its acidic activating domain. In this report we show that these cells are selectively impaired in their capacity to support the lytic infectious cycle of HSV-1, and that this impairment results from their inability to support immediate early transcription.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843776     DOI: 10.1038/335452a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  52 in total

1.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0.

Authors:  K L Mossman; J R Smiley
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  The VP16 paradox: herpes simplex virus VP16 contains a long-range activation domain but within the natural multiprotein complex activates only from promoter-proximal positions.

Authors:  M Hagmann; O Georgiev; W Schaffner
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Multimerization of ICP0, a herpes simplex virus immediate-early protein.

Authors:  J Chen; C Panagiotidis; S Silverstein
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Can HIV be cured with stem cell therapy?

Authors:  Steven G Deeks; Joseph M McCune
Journal:  Nat Biotechnol       Date:  2010-08       Impact factor: 54.908

5.  The tnpA and tnpD gene products of the Spm element are required for transposition in tobacco.

Authors:  P Masson; M Strem; N Fedoroff
Journal:  Plant Cell       Date:  1991-01       Impact factor: 11.277

6.  Packaging of the virion host shutoff (Vhs) protein of herpes simplex virus: two forms of the Vhs polypeptide are associated with intranuclear B and C capsids, but only one is associated with enveloped virions.

Authors:  G Sullivan Read; Mary Patterson
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

7.  Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50.

Authors:  Brigitte Rupp; Zsolt Ruzsics; Christopher Buser; Barbara Adler; Paul Walther; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

8.  A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.

Authors:  M Federico; F Nappi; G Ferrari; C Chelucci; F Mavilio; P Verani
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  The extreme carboxyl terminus of the equine herpesvirus 1 homolog of herpes simplex virus VP16 is essential for immediate-early gene activation.

Authors:  G D Elliott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Targeting tat inhibitors in the assembly of human immunodeficiency virus type 1 transcription complexes.

Authors:  Iván D'Orso; Jocelyn R Grunwell; Robert L Nakamura; Chandreyee Das; Alan D Frankel
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.